打开APP
userphoto
未登录

开通VIP,畅享免费电子书等14项超值服

开通VIP
热心肠日报
Molecular Pharmaceutics
[IF:4.556]

Diammonium Glycyrrhizinate Protects against Non-Alcoholic Fatty Liver Disease in mice through modulation of gut microbiota and restoring intestinal barrier

DOI: 10.1021/acs.molpharmaceut.8b00347

Abstract & Authors   展开

Abstract:
Nonalcoholic fatty liver disease (NAFLD), as a common chronic liver disorder, is prevalent in the world. Recent evidence demonstrates that the 'gut-liver axis' is related well to the progression of NAFLD, which regards gut microbiota and intestinal barrier as two critical factors correlated with NAFLD. Diammonium glycyrrhizinate (DG), a compound of natural bioactive pentacyclic triterpenoid glycoside, is the main component of licorice roots extracts. The anti-inflammatory and liver protection effects of DG have already been reported, but to date, the mechanism has not been fully elucidated. In this research, we observed that DG reduced body weight, liver steatosis, as well as hepatic inflammatory in NAFLD model mice induced by high fat diet. Illumina sequencing of the 16S rRNA revealed that DG intervention notably altered the composition of the gut microbiota in NAFLD mice. The richness of gut microbiota was significantly increased by DG. Specifically, DG reduced the Firmicutes-to-Bacteroidetes ratio and the endotoxin-producing bacteria such as Desulfovibrio, and elevated the abundance of probiotics such as Proteobacteria and Lactobacillus. Interestingly DG could augment the levels of short-chain fatty acids (SCFAs)-producing bacteria such as Ruminococcaceae and Lachnospiraceae and promote SCFAs production. In addition, DG supplementation dramatically alleviated the intestinal low-grade inflammation. Meanwhile, DG improved the expression of tight junction proteins, the goblet cells number and mucin secretion, and sequentially enhanced the function of intestinal barrier. Collectively, the prevention of NAFLD by DG might be mediated by modulating gut microbiota and restoring intestinal barrier.

First Authors:
Yun Li,Tianyu Liu

Correspondence:
Hailong Cao

All Authors:
Yun Li,Tianyu Liu,Chen Yan,Runxiang Xie,Zixuan Guo,Sinan Wang,Yujie Zhang,Zhengxiang Li,Bangmao Wang,Hailong Cao

7/23/18Article

本站仅提供存储服务,所有内容均由用户发布,如发现有害或侵权内容,请点击举报
打开APP,阅读全文并永久保存 查看更多类似文章
猜你喜欢
类似文章
【热】打开小程序,算一算2024你的财运
超实用干货帖 | 微生物领域选刊指南之四:肠道菌群选刊指南
急性肝损伤与肠道菌群失调什么关系? | 热心肠日报
专家论坛|胡义扬:肠道微生态——中医药治疗非酒精性脂肪性肝病的重要靶位
梅奥特邀述评:肠道微生物组在非酒精性脂肪性肝病中的作用
A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice | Nature Medicine
你能跑多久,肠道菌群说了算?
更多类似文章 >>
生活服务
热点新闻
分享 收藏 导长图 关注 下载文章
绑定账号成功
后续可登录账号畅享VIP特权!
如果VIP功能使用有故障,
可点击这里联系客服!

联系客服